Literature DB >> 12661911

Blood pressure-lowering effects of biofeedback treatment in hypertension: a meta-analysis of randomized controlled trials.

Mutsuhiro Nakao1, Eiji Yano, Shinobu Nomura, Tomifusa Kuboki.   

Abstract

To examine the blood pressure-lowering effects of biofeedback treatment in patients with essential hypertension, a meta-analysis was conducted on studies published between 1966 and 2001. A total of 22 randomized controlled studies with 905 essential hypertensive patients were selected for review. Compared with clinical visits or self-monitoring of blood pressure (non-intervention controls), biofeedback intervention resulted in systolic and diastolic blood pressure reductions that were greater by 7.3 mmHg (for systole; 95% confidence interval: 2.6 to 12.0) and 5.8 mmHg (for diastole; 95% confidence interval: 2.9 to 8.6). Compared with sham or non-specific behavioral intervention controls, the net reductions in systolic and diastolic blood pressures by biofeedback intervention were 3.9 (95% confidence interval: -0.3 to 8.2) and 3.5 (-0.1 to 7.0) mmHg, respectively. The results of multiple regression analysis also indicated that biofeedback intervention decreased systolic and diastolic blood pressures more than non-intervention controls (p < 0.001), but not more than sham or non-specific behavioral intervention controls (p > 0.05), when controlling for the effects of initial blood pressures. When biofeedback intervention types were classified into two types, simple biofeedback and relaxation-assisted biofeedback, only the relaxation-assisted biofeedback significantly decreased both systolic and diastolic blood pressures (p < 0.05) compared with those in sham or non-specific behavioral intervention controls. The results suggested that biofeedback was more effective in reducing blood pressure in patients with essential hypertension than no intervention. However, the treatment was only found to be superior to sham or non-specific behavioral intervention when combined with other relaxation techniques. Further studies will be needed to determine whether biofeedback itself has an antihypertensive effect beyond the general relaxation response.

Entities:  

Mesh:

Year:  2003        PMID: 12661911     DOI: 10.1291/hypres.26.37

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  8 in total

Review 1.  Estimation of blood glucose levels by people with diabetes: a cross-sectional study.

Authors:  Stuart Frankum; Jane Ogden
Journal:  Br J Gen Pract       Date:  2005-12       Impact factor: 5.386

Review 2.  Cholinergic control of inflammation.

Authors:  M Rosas-Ballina; K J Tracey
Journal:  J Intern Med       Date:  2009-06       Impact factor: 8.989

Review 3.  Stress reduction programs in patients with elevated blood pressure: a systematic review and meta-analysis.

Authors:  Maxwell V Rainforth; Robert H Schneider; Sanford I Nidich; Carolyn Gaylord-King; John W Salerno; James W Anderson
Journal:  Curr Hypertens Rep       Date:  2007-12       Impact factor: 5.369

Review 4.  The perspective of psychosomatic medicine on the effect of religion on the mind-body relationship in Japan.

Authors:  Mutsuhiro Nakao; Chisin Ohara
Journal:  J Relig Health       Date:  2014-02

Review 5.  Role of complementary and alternative medicine in geriatric care: A mini review.

Authors:  Mohammad Jamshed Siddiqui; Chan Sze Min; Rohit Kumar Verma; Shazia Qasim Jamshed
Journal:  Pharmacogn Rev       Date:  2014-07

Review 6.  Virtual Reality Biofeedback in Health: A Scoping Review.

Authors:  Robin Lüddecke; Anna Felnhofer
Journal:  Appl Psychophysiol Biofeedback       Date:  2021-12-03

7.  Failure of psychological interventions to lower blood pressure: a randomized controlled trial.

Authors:  Marco I Perez; Wolfgang Linden; Thomas Perry; Lorri J Puil; James M Wright
Journal:  Open Med       Date:  2009-06-09

8.  Locus of control and anti-hypertensive medication adherence in Ghana.

Authors:  Irene Akwo Kretchy; Frances Thelma Owusu-Daaku; Samuel Danquah
Journal:  Pan Afr Med J       Date:  2014-01-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.